UNO Minda Q2 FY27: consolidated PAT up 37% YoY to ₹441 Cr, revenue +38% to ₹6,655 Cr
PAT +36.56% YoY · revenue +38.25% · margins compressing · beat vs street
₹6,655.42 Cr
+38.25% YoY
₹440.81 Cr
+36.56% YoY
6.62%
-0.1pp YoY
₹7.27
UNO Minda's consolidated revenue came in at ₹6,655.42 Cr, up 38.2% YoY from ₹4,814.03 Cr and 19.8% QoQ from ₹5,556.85 Cr. Net profit for the period was ₹440.81 Cr, up 36.6% YoY (₹322.79 Cr) and 39.7% QoQ (₹315.51 Cr); the owners' share was ₹419.72 Cr, up 38.1% YoY. Basic EPS rose to ₹7.27 from ₹5.28 a year ago. Neither this quarter nor the year-ago quarter carried exceptional items, so these are clean, unadjusted comparisons. Standalone told a softer story — revenue ₹4,907.98 Cr (+35.1% YoY) but PAT of just ₹392.58 Cr (+16.0% YoY) — with the gap versus consolidated driven almost entirely by a 29% YoY drop in standalone other income (dividends from subsidiaries fell to ₹83.31 Cr from ₹115.55 Cr), an intercompany flow that nets out on consolidation rather than a sign of weaker operations.
Q2 FY-2027 vs prior quarters
The print came in well above Street. Informist's brokerage consensus had pegged the quarter at revenue of roughly ₹4,795 Cr and PAT of roughly ₹281 Cr, with EBITDA margin seen contracting about 36bps YoY; UNO Minda's actual topline and bottom line both landed well clear of those averages. Margins were mixed depending on the reference period: operating margin (PBT before JV/associate share and exceptional items, adjusted for depreciation, finance cost and other income, over revenue from operations) was 11.02%, down 44bps from 11.46% a year ago but up 73bps sequentially from 10.29% in Q1 FY27; net profit margin was 6.62%, down a slim 8bps YoY but up 95bps QoQ. Against management's own FY27 guidance of 11% EBITDA margin ±50bps with a stated bias toward the higher end (given on the August concall), the 11.02% print sits mid-band — on track with guidance, but not yet showing the higher-end bias management had flagged.
The stock went into the print at ₹1,307.3, up 16.7% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.
FY27 EBITDA margins 11% ±50 bps (bias to higher end), capex INR 1,750 Cr, continued healthy growth. New product ramps: seating (Q2 FY28 ops), sunroof (end FY27 start, peak FY29), Inovance (subject to China regulatory clarity, timeline TBD).
— This quarter: met
The quarter's capex pipeline stayed active alongside the result. The Board approved an incremental ₹85 Cr for sunroof capacity at Bawal (adding 2,91,000 units p.a., SOP targeted from Q2 FY28), layered on the existing 1,45,000-unit line still awaiting its own March-2027 start-up — consistent with the 'sunroof capacity to start end-FY27, peak FY29' timeline management laid out last quarter. That sits alongside the ₹1,415 Cr four-project expansion approved September 15, the ₹1,500 Cr+ capacity/NCD approval from September 14, and two ₹100 Cr commercial paper issuances (September 25, October 28) funding working capital through the ramp. The Board also approved a leadership reshuffle effective November 5: Nitesh Minda becomes CEO-designate of the SCS Domain ahead of A.G. Giridharan's retirement, Kartikeya Joshi is elevated to Chief Marketing Officer, and Amit Jain is re-designated Group Chief Growth and Technology Officer with expanded EV and manufacturing-excellence oversight.
W1
Sunroof SOP: existing 1,45,000-unit Bawal line guided for March 2027 (end-FY27); the new 2,91,000-unit expansion (₹85 Cr) targets SOP from Q2 FY28 — watch for on-schedule commissioning.
W2
FY27 EBITDA margin guided at 11% ±50bps with a bias to the higher end; Q2 printed 11.02% — watch whether H2 pushes toward the upper band as guided.
W3
Seating JV ramp targeted for Q2 FY28 start; Inovance timeline remains pending China regulatory clarity — watch for an update on the next call.
Informational and educational content only. Not investment advice.